Piramal Pharma Limited (PPLPHARMA)

Volume: 1,38,59,791Avg Vol 1W: 1,58,18,526.2Avg Vol 1M: 96,35,860.552W Range:₹132.3₹220.85

₹163.35▼ 0.20%

Key Ratios

Market Cap₹21,814 Cr

Current Price₹163.35

Previous Close₹163.67

High / Low (52w)₹220.85 / ₹132.3

Volume1,38,59,791

Avg Vol (1W)1,58,18,526.2

Avg Vol (1M)96,35,860.5

Stock P/E—

Book Value₹61.5

Dividend Yield0%

ROE-3.6%

ROA-1.8%

Revenue (TTM)₹9,286 Cr

Revenue Growth12%

Profit Margin-3.7%

Total Debt₹3,214 Cr

Shares Outstanding133 Cr

Face Value₹10

EPS (TTM)₹-0.07

P/B2.67

Debt / Equity0.7

50 DMA₹152.25

200 DMA₹177.11

Day change-0.20%

Price Chart

₹163.35▼ 16.02% · 1Y

2025-06-17

2026-05-11

20-day avg volume: 96.4L shares

Pros

Quarterly Results

Metric	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	₹1,951 Cr	₹2,242 Cr	₹2,204 Cr	₹2,754 Cr	₹1,934 Cr	₹2,044 Cr	₹2,140 Cr	₹2,752 Cr
EBITDA	₹39 Cr	₹211 Cr	₹153 Cr	₹360 Cr	₹-32 Cr	₹21 Cr	₹26 Cr	₹288 Cr
Net Profit	₹-89 Cr	₹23 Cr	₹4 Cr	₹154 Cr	₹-82 Cr	₹-99 Cr	₹-136 Cr	₹-9 Cr
EPS	—	—	—	—	—	—	—	—

Profit & Loss (Annual)

Metric	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Revenue	₹6,479 Cr	₹6,835 Cr	₹7,307 Cr	₹8,347 Cr	₹9,286 Cr
EBITDA	₹1,047 Cr	₹639 Cr	₹177 Cr	₹631 Cr	₹763 Cr
Net Profit	₹835 Cr	₹376 Cr	₹-186 Cr	₹18 Cr	₹91 Cr
EPS	—	—	—	—	—

Balance Sheet

Metric	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Assets	₹10,900 Cr	₹12,797 Cr	₹14,523 Cr	₹15,312 Cr	₹15,678 Cr
Total Liabilities	₹5,295 Cr	₹6,100 Cr	₹7,749 Cr	₹7,400 Cr	₹7,552 Cr
Equity	₹5,605 Cr	₹6,697 Cr	₹6,774 Cr	₹7,911 Cr	₹8,125 Cr
Total Debt	₹2,339 Cr	₹2,622 Cr	₹3,384 Cr	₹2,484 Cr	₹3,214 Cr

Cash Flow

Metric	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Operating	₹742 Cr	₹936 Cr	₹673 Cr	₹1,161 Cr	₹1,227 Cr
Investing	₹-4,480 Cr	₹-1,812 Cr	₹-1,339 Cr	₹-434 Cr	₹-477 Cr
Financing	₹3,977 Cr	₹794 Cr	₹818 Cr	₹-422 Cr	₹-441 Cr
Free Cash Flow	₹742 Cr	₹936 Cr	₹673 Cr	₹1,161 Cr	₹1,227 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search